Sai Life Sciences is planning to raise INR50B via Indian IPO. The IPO consists of a fresh issue of INR8B and OFS of up to ~62M shares by its existing shareholders and promoters.
What is covered in the Full Insight:
Company Background
Issue Size
Objects of the Offer
Key Investment Rationale
Key Financial Information
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.